These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
716 related articles for article (PubMed ID: 23504663)
21. Clinical evaluation and molecular screening of a large consecutive series of albino patients. Mauri L; Manfredini E; Del Longo A; Veniani E; Scarcello M; Terrana R; Radaelli AE; Calò D; Mingoia G; Rossetti A; Marsico G; Mazza M; Gesu GP; Cristina Patrosso M; Penco S; Piozzi E; Primignani P J Hum Genet; 2017 Feb; 62(2):277-290. PubMed ID: 27734839 [TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of oculocutaneous albinism: a compact review. Kamaraj B; Purohit R Biomed Res Int; 2014; 2014():905472. PubMed ID: 25093188 [TBL] [Abstract][Full Text] [Related]
23. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism. Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014 [TBL] [Abstract][Full Text] [Related]
24. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B). Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292 [TBL] [Abstract][Full Text] [Related]
25. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families. Wei AH; Zang DJ; Zhang Z; Yang XM; Li W J Genet Genomics; 2015 Jun; 42(6):279-86. PubMed ID: 26165494 [TBL] [Abstract][Full Text] [Related]
26. High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene. Morice-Picard F; Lasseaux E; Cailley D; Gros A; Toutain J; Plaisant C; Simon D; François S; Gilbert-Dussardier B; Kaplan J; Rooryck C; Lacombe D; Arveiler B Pigment Cell Melanoma Res; 2014 Jan; 27(1):59-71. PubMed ID: 24118800 [TBL] [Abstract][Full Text] [Related]
27. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586 [TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of a Chinese family with oculocutaneous albinism. Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221 [TBL] [Abstract][Full Text] [Related]
30. Genetic analyses of Chinese patients with digenic oculocutaneous albinism. Wei AH; Yang XM; Lian S; Li W Chin Med J (Engl); 2013 Jan; 126(2):226-30. PubMed ID: 23324268 [TBL] [Abstract][Full Text] [Related]
31. Genetic studies of multiple consanguineous Pakistani families segregating oculocutaneous albinism identified novel and reported mutations. Gul H; Shah AH; Harripaul R; Mikhailov A; Prajapati K; Khan E; Ullah F; Zubair M; Ali MZ; Shah AH; Salman S; Khan S; Vincent JB; Khan MA Ann Hum Genet; 2019 Jul; 83(4):278-284. PubMed ID: 30868578 [TBL] [Abstract][Full Text] [Related]
33. Delineating the genetic heterogeneity of OCA in Hungarian patients. Fábos B; Farkas K; Tóth L; Sulák A; Tripolszki K; Tihanyi M; Németh R; Vas K; Csoma Z; Kemény L; Széll M; Nagy N Eur J Med Res; 2017 Jun; 22(1):20. PubMed ID: 28629449 [TBL] [Abstract][Full Text] [Related]
35. Delineating Novel and Known Pathogenic Variants in Shakil M; Akbar A; Aisha NM; Hussain I; Ullah MI; Atif M; Kaul H; Amar A; Latif MZ; Qureshi MA; Mahmood S Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328057 [TBL] [Abstract][Full Text] [Related]
36. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism. Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807 [TBL] [Abstract][Full Text] [Related]
37. Genetic analysis and prenatal diagnosis of 20 Chinese families with oculocutaneous albinism. Xu C; Xiang Y; Li H; Xu Y; Mao Y; Zhou L; Xu X; Tang S J Clin Lab Anal; 2021 Feb; 35(2):e23647. PubMed ID: 33124154 [TBL] [Abstract][Full Text] [Related]
38. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase. Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744 [TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of Korean patients with oculocutaneous albinism. Park SH; Chae H; Kim Y; Kim M Jpn J Ophthalmol; 2012 Jan; 56(1):98-103. PubMed ID: 22042571 [TBL] [Abstract][Full Text] [Related]
40. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations. Chen C; Li J; Wang B; Wang Y; Yu X Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]